The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9

NCT05438875 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG: all-trans retinoic acid
DRUG: Eltrombopag

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]